"Neuromed - Istituto Neurologico Mediterraneo è un Istituto di Ricovero e Cura a Carattere Scientifico(I.R.C.C.S.) e un centro di rilevanza nazionale e di altissima specializzazione per patologie afferenti alla Neurochirurgia, Neurologia, Riabilitazione(cod.56,75-1 e 75-2) e Chirurgia Vascolare ed Endovascolare. È riconosciuto dal Ministero della Salute e dalla Regione Molise tra i centri che si distinguono per la qualità delle cure e la capacità di trasferire i risultati della ricerca e nellattività clinica quotidiana(ricerca traslazionale). Neuromed è convenzionato con il SSN e al cuore della sua missione cè una forte integrazione tra Cura, Ricerca e Didattica."

During the past decade, IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA" in a lesser frequency.

Most popular intervention types in "IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Gantenerumab" (3 trials), "Crenezumab" (1 trials), "Semorinemab" (1 trials) and "[18F]GTP1" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA" are 5 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".